Global  

Trusted News Discovery Since 2008
One News Page
One News Page > Press Releases News > Publication in Cancer Research Demonstrates Crescendo Biologics’ Humabody® VH Therapeutics Outperform Conventional Antibodies in Vivo

Publication in Cancer Research Demonstrates Crescendo Biologics’ Humabody® VH Therapeutics Outperform Conventional Antibodies in Vivo

Business Wire Wednesday, 15 January 2020
Publication in Cancer Research Demonstrates Crescendo Biologics’ Humabody® VH Therapeutics Outperform Conventional Antibodies in VivoCAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted, T cell enhancing therapeutics, announces the publication of a paper that demonstrates greater tissue penetration and in vivo efficacy of Humabody® VH therapeutics compared to conventional antibody formats, in the scientific journal Cancer Research a journal of the American Association for Cancer Research. The full paper by Nessler et al can be accessed online HERE. The study run by D
0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

Zelira Therapeutics fully enrols cannabis clinical trial

Zelira Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) has now fully enrolled its Phase 1 Dose Escalation Trial in patients on long-term opioid treatment. The trial is...
Proactive Investors

VolitionRx unveils new epigenetic toolbox off new research into Nu.Q Capture program

VolitionRx Limited (NYSEAMERICAN:VNRX) is unveiling a new epigenetic toolbox thanks to new research on its Nu.Q Capture program.  The Austin, Texas-based...
Proactive Investors

You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.